Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Karin Burock"'
Autor:
Franco Locatelli, Bulent Antmen, Hyoung Jin Kang, Katsuyoshi Koh, Yoshiyuki Takahashi, Alphan Kupesiz, Maria Gabriela Matos, Donna Wall, Sunil Bhat, Ho Joon Im, Tayfun Gungor, Meng-Yao Lu, Tommaso Stefanelli, Christine Rosko, Annie St. Pierre, Karin Burock, Cristina Diaz-De-Heredia
Publikováno v:
HemaSphere, Vol 7, p e54405ff (2023)
Externí odkaz:
https://doaj.org/article/a8dc3d936beb42a9ae950ba84c082f88
Autor:
Steven Sparagana, David N Franz, Darcy A Krueger, John J Bissler, Noah Berkowitz, Karin Burock, J Christopher Kingswood
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186235 (2017)
To determine the impact of everolimus on female fertility, including menstrual irregularities, secondary amenorrhea, and luteinizing and follicle stimulating hormone levels in female patients.A pooled analysis from 3 prospective studies consisting of
Externí odkaz:
https://doaj.org/article/6aac383e5ef941a9bb987146b6000040
Autor:
Raoul Herbrecht, Robert Pack, Monika Wroclawska, Rüdiger Liersch, Burkhard Schmidt, Fiorenza Barraco, Heinz Gisslinger, Reinier Raymakers, Andreas Reiter, Richard Greil, Divyadeep Karumanchi, Wolfgang Willenbacher, Karin Burock
Publikováno v:
British Journal of Haematology. 191:764-774
Primary objective of this non-interventional, post-authorisation safety study was to provide real-world safety data [incidence of adverse drug reactions (ADRs)/serious adverse events (SAEs)] on adult patients with myelofibrosis exposed/or not exposed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4551258c6d7675271bfc75ccafbed541
https://doi.org/10.1111/bjh.16729
https://doi.org/10.1111/bjh.16729
Autor:
Karin Burock, J. Christopher Kingswood, Steven Sparagana, Noah Berkowitz, John J. Bissler, Darcy A. Krueger, David Neal Franz
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0186235 (2017)
PLoS ONE
PLoS ONE
Objectives To determine the impact of everolimus on female fertility, including menstrual irregularities, secondary amenorrhea, and luteinizing and follicle stimulating hormone levels in female patients. Design A pooled analysis from 3 prospective st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e784a16c61434d03425063149ad2bac
http://europepmc.org/articles/PMC5638404?pdf=render
http://europepmc.org/articles/PMC5638404?pdf=render
Autor:
Jessie Zou, Yoon-Koo Kang, Jiwei Liu, Chao Jung Tsao, Ann-Lii Cheng, Jun Suk Kim, Karin Burock, Jiejun Wang, Houjie Liang, Rongcheng Luo, Jianming Xu, Shukui Qin, Zhongzhen Guan, Jifeng Feng, Yan Sun, D. Voliotis, Sheng-Long Ye, Hongming Pan, Tsai Sheng Yang, Zhendong Chen, Won Young Tak
Publikováno v:
The Lancet Oncology. 10:25-34
Summary Background Most cases of hepatocellular carcinoma occur in the Asia-Pacific region, where chronic hepatitis B infection is an important aetiological factor. Assessing the efficacy and safety of new therapeutic options in an Asia-Pacific popul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45eed098d16f912b598d6e6c51e3c501
https://doi.org/10.1016/s1470-2045(08)70285-7
https://doi.org/10.1016/s1470-2045(08)70285-7
Publikováno v:
Contraception. 87(1)
Background The study was conducted to characterize the changes in bleeding pattern over time in women receiving the levonorgestrel-releasing intrauterine system (LNG-IUS) for heavy menstrual bleeding (HMB). The reduction in menstrual blood loss volum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a6c5ce48d5761e1cede15d9f081996c
https://pubmed.ncbi.nlm.nih.gov/23040140
https://pubmed.ncbi.nlm.nih.gov/23040140
Autor:
Hans Walter Lindemann, M. Frick, Karin Burock, Bernd Metzner, Oleg Gluz, Carl Richard Meier, H.-H. Wolf, Axel R. Zander, M Hänel, Andreas Neubauer, Christian Jackisch, Gerhard Ehninger, Hans Peter Lohrmann, Kathrin Kolbe, Ute Ruffert, Heinrich Bodenstein, Yon Ko, Ulrike Nitz, Svjetlana Mohrmann, Nicolaus Kröger
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 24(24)
Purpose To compare progression-free survival between single and tandem high-dose chemotherapy (HDT) followed by autologous stem-cell transplantation in chemotherapy-sensitive metastatic breast cancer patients. Patients and Methods Between February 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a7da37647c10de0ad5551f29df16851
https://pubmed.ncbi.nlm.nih.gov/16921043
https://pubmed.ncbi.nlm.nih.gov/16921043